Given the agency's recent history of granting Priority Review to novel obesity agents with breakthrough designation potential, a six-month review clock would place a potential approval in the first half of 2026
However, members who pay coinsurance rather than a flat copay may see lower costs at the pharmacy counter, while employers may pay a slightly larger share of total costs for Wegovy, Ozempic and Rybelsus
[Cut to Alexandra, a CVS Pharmacist, 8 years.] Alexandra, speaking: For diabetes, weve definitely seen the benefit that it can have in controlling blood sugar and your A1C
Only 23% of low early responders eventually reached 15% total weight loss by study end
You would not know the concentration has dropped until you notice reduced effectiveness
Add-ons like B12 or amino blends are available for additional support